Triple-hit lymphoma (THL) that carries concurrent MYC, BCL2 and BCL6 rearrangements is a relatively rare subset, identified in approximately 1% of DLBCL patients (4–6). Here, MYC is linked to diffuse large B-cell lymphoma.